Department of Urology, Erasmus MC Cancer Institute, University Medical Center Rotterdam, Rotterdam, The Netherlands.
Department of Urology, Erasmus MC Cancer Institute, University Medical Center Rotterdam, Rotterdam, The Netherlands; Cancer Computational Biology Center, Erasmus MC Cancer Institute, University Medical Center Rotterdam, Rotterdam, The Netherlands.
Urol Oncol. 2020 Jun;38(6):590-598. doi: 10.1016/j.urolonc.2020.01.008. Epub 2020 Feb 11.
Following radical nephroureterectomy for upper urinary tract urothelial carcinoma (UTUC), intravesical recurrence (IVR) is found in 22% to 47% of patients. Patients with a primary urothelial carcinoma of the bladder (UCB) have an increased risk of a future UTUC (1%-5%). Paired UTUC and UCB might represent clonally related tumors due to intraluminal seeding of tumor cells or might be separate entities of urothelial carcinoma caused by field cancerization. We systematically reviewed all the relevant literature to address the possible clonal relation of UTUC and paired UCB.
MEDLINE, EMBASE, and COCHRANE databases were systematically searched for relevant citations published between January 2000 and July 2019. This study was performed according to the Preferred Reporting Items for Systematic Reviews and Meta-analyses guidelines. Of 5038 citations identified, 86 full papers were screened, and 9 studies met the inclusion criteria.
The populations studied and the molecular techniques used to assess clonality of UTUC and paired UCB differed largely over time. Eight studies reported on primary UTUC and meta- or synchronous IVR without a history of UCB. A total of 118 tumors (55 UTUC and 63 IVR) from 49 patients were included, of which 94% seemed to be clonally related. Five studies reported on primary UCB and subsequent UTUC with a total of 61 tumors (30 UCB and 31 UTUC) from 14 patients; a possible clonal origin was identified for 85% of the tumors.
Taking into account the limitations of microsatellite technology in comparison to Next Generation Sequencing and currently accepted concepts of tumor heterogeneity and evolution, this systematic review shows that most, if not all, UTUC and paired UCB likely are clonally related.
在上尿路尿路上皮癌(UTUC)根治性肾输尿管切除术(radical nephroureterectomy)后,有 22%-47%的患者会出现膀胱内复发(IVR)。患有原发性膀胱癌(UCB)的患者发生 UTUC 的风险增加(1%-5%)。配对的 UTUC 和 UCB 可能由于肿瘤细胞腔内播散而代表克隆相关肿瘤,也可能是由于局灶性癌变而导致的不同的尿路上皮癌实体。我们系统地回顾了所有相关文献,以探讨 UTUC 和配对 UCB 之间可能存在的克隆关系。
系统地检索了 2000 年 1 月至 2019 年 7 月间 MEDLINE、EMBASE 和 Cochrane 数据库中相关的文献。本研究按照系统评价和荟萃分析的首选报告项目进行。在 5038 条引文中共筛选出 86 篇全文,并纳入了 9 项研究。
研究人群和用于评估 UTUC 和配对 UCB 克隆性的分子技术在时间上差异很大。8 项研究报告了原发性 UTUC 和没有膀胱癌病史的meta 或同步 IVR。共纳入了 49 名患者的 118 个肿瘤(55 个 UTUC 和 63 个 IVR),其中 94%似乎具有克隆相关性。5 项研究报告了原发性 UCB 后发生的后续 UTUC,共纳入了 14 名患者的 61 个肿瘤(30 个 UCB 和 31 个 UTUC);85%的肿瘤可能具有克隆起源。
考虑到与下一代测序相比,微卫星技术的局限性以及目前公认的肿瘤异质性和进化概念,本系统评价表明,大多数(如果不是全部)UTUC 和配对 UCB 很可能具有克隆相关性。